Research programme: glucagon-like peptide-1 analogues oral - Unigene

Drug Profile

Research programme: glucagon-like peptide-1 analogues oral - Unigene

Alternative Names: GLP-1 analogues oral

Latest Information Update: 29 Apr 2011

Price : $50

At a glance

  • Originator Unigene Laboratories
  • Class
  • Mechanism of Action Glucagon-like peptide 1 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Type 2 diabetes mellitus

Most Recent Events

  • 04 Apr 2008 Preclinical development is ongoing
  • 09 Sep 2005 The programme is available for licensing worldwide (http://www.unigene.com)
  • 09 Sep 2005 Preclinical trials in Type-2 diabetes mellitus in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top